Navigation Links
PAREXEL Completes 200 Patient Studies In Its Early Phase Units Over Three Years
Date:11/17/2010

and access to local healthcare professionals through PAREXEL's hospital-based units.  PAREXEL's early phase units are strategically located to facilitate rapid patient recruitment.  

As biopharmaceutical companies strive to manage development costs, gather dose range data sooner, accelerate development timelines, and obtain earlier efficacy signals, PAREXEL helps meet these multiple goals in early stage development.  PAREXEL's early phase services provide fully integrated solutions from First in Man through Proof-of-Concept and help biopharmaceutical companies seeking to return solid, reproducible outcomes to succeed in later-phase trials.

PAREXEL's early phase units are located across three continents, including in Baltimore and Los Angeles in the United States; London, United Kingdom; Berlin, Germany; and Bloemfontein, George, and Port Elizabeth, South Africa. PAREXEL's early phase capabilities include a full scope of early phase studies, specialized trial design, state-of-the-art technologies, hospital-based resources, and scientific expertise as well as vast experience in the oncology, neurology, cardiology, respiratory, and metabolism/endocrine therapeutic areas. For more information about PAREXEL's early phase capabilities visit: http://www.PAREXEL.com/Early_Phase.html.

About PAREXEL International PAREXEL International Corporation is a leading global bio/pharmaceutical services organization, providing a broad range of knowledge-based contract research, consulting, and medical communications services to the worldwide pharmaceutical, biotechnology and medical device industries. Committed to providing solutions that expedite time-to-market and peak-market penetration, PAREXEL has developed significant expertise across the development and commercialization continuum, from drug de
'/>"/>

SOURCE PAREXEL International Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology news :

1. Team completes world-first ocean observatory
2. University of Hawaii completes 3-year investigation of military munitions sea disposal site
3. Kornberg Associates
4. Architects Completes UC Riverside Stem Cell Core Facility Project
5. KINAXO Completes Financing Round to Enhance Biomarker Development
6. Pacific Biometrics Completes $4 Million Debt Financing
7. InVitria Successfully Completes Beta Testing and Announces Commercial Launch of Optiferrin for Mammalian Cell Culture
8. Lockheed Martin Team Completes Key Design Milestone on Federal Bureau of Investigations Next Generation Identification Program
9. Funxional successfully completes initial clinical trial of FX125L, an anti-inflammatory drug with a novel mechanism of action
10. DOE Joint Genome Institute completes soybean genome
11. Arsenic early in treatment improves survival for leukemia patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... changing climate threaten some of the world,s most ... establish seed collections to save the seeds in ... some genetic diversity., For decades, these seed collections ... a one-size-fits-all approach for how many seeds to ... regardless of species, pollination mode, growth habitat and ...
(Date:7/30/2014)... they eat, the Food and Drug Administration (FDA) earlier ... label found on nearly every food product in the ... (C&EN), the weekly news magazine of the American ... fight that has ensued. , Britt Erickson, a senior ... Facts label has remained largely the same for two ...
(Date:7/30/2014)... from Wayne State University,s College of Engineering recently ... Foundation for the project, "Nanoparticle-directed synthesis of organic ... Foundation, nanotechnology is the creation and utilization of ... and functions. A major bottleneck in scaling up ... connect different functional materials into one device. A ...
Breaking Biology News(10 mins):Saving seeds the right way can save the world's plants 2NSF grant to Wayne State supports new concept for manufacturing nanoscale devices 2
... amorous midshipman fish to the strains of a Puccini aria ... neural circuitry that led to the human love song not ... of vertebrates was likely laid down hundreds of millions of ... By mapping the developing brain cells in newly hatched midshipman fish ...
... for food service and salad mixes is an increasingly ... perishable, and the cutting required in processing further shortens ... fresh produce in semipermeable plastic films extends shelf life ... modified-atmosphere (MA) packaging for lettuce and certain salad greens ...
... joining forces to conceptualize, develop and bring to reality ... care through UC San Diego,s new Institute of Engineering ... to repair damaged hearts, and scarless surgery techniques are ... with the new Institute leading the way. "As ...
Cached Biology News:From humming fish to Puccini: Vocal communication evolved with ancient species 2Good breeding increases shelf life 2UC San Diego launches Institute of Engineering in Medicine to accelerate health care tech 2UC San Diego launches Institute of Engineering in Medicine to accelerate health care tech 3
(Date:7/30/2014)... 2014  Orexigen Therapeutics, Inc. (Nasdaq: OREX ... List of Outstanding Issues (LOI) from the European Medicines ... for the NB32 Marketing Authorization Application (MAA). NB32 (naltrexone ... drug candidate being evaluated for weight loss. ... point were adequately addressed by the Company based in ...
(Date:7/30/2014)... July 30, 2014 Researchers often use ... biology, but such devices can do much more ... As such, researchers have looked to patterned assemblies ... metabolic engineering to characterize – and potentially ... devices are envisioned to recreate animal and human ...
(Date:7/30/2014)... 2014  AtheroNova Inc. (OTCBB: AHRO), a biotech ... compounds to safely regress atherosclerotic plaque and improve ... partner, CardioNova, has accomplished first dosing of subjects ... lead compound, AHRO-001.  This Phase 1b trial will ... safety trial completed in February 2014, in which ...
(Date:7/30/2014)... (PRWEB) July 30, 2014 NCERC ... Athmanathan will present his findings on corn stover ... conference this week in Washington, D.C. , ... Energy conference is a testament to the success ... Caupert said. “Thanks to the foresight and vision ...
Breaking Biology Technology:Orexigen Receives CHMP Day 180 List of Outstanding Issues 2Orexigen Receives CHMP Day 180 List of Outstanding Issues 3UMD Researchers Bridge Gap between Microelectronics, Biological Systems 2UMD Researchers Bridge Gap between Microelectronics, Biological Systems 3UMD Researchers Bridge Gap between Microelectronics, Biological Systems 4AtheroNova Announces Milestone with Initiation of Phase 1b Clinical Trial of AHRO-001 2AtheroNova Announces Milestone with Initiation of Phase 1b Clinical Trial of AHRO-001 3AtheroNova Announces Milestone with Initiation of Phase 1b Clinical Trial of AHRO-001 4NCERC at SIUE Researcher Takes Stage at Department of Energy Conference 2NCERC at SIUE Researcher Takes Stage at Department of Energy Conference 3
... HILL, England, September 1 , With some ... to start the,new school year, new guidance from ... looks set to revolutionise the way children,manage their ... by greater access to insulin pump therapy. The ...
... treatment of HIV-positive individuals with American Biotech ... improvement in the condition of the subjects after ... nanosilver particles can block entry of the ... ALPINE, UT, Aug. 29 /PRNewswire-FirstCall/ - American Biotech ...
... Corporation,(Nasdaq: PARS ) today announced that effective ... Israel, and manage those activities currently,based in Rehovot ... New,Jersey., The research programs in Israel are ... development of PRS-639,058 for,neuropathic pain. Additionally the Company ...
Cached Biology Technology:British School Kids With Diabetes Gain First Time Freedom From Injections With New Insulin Pump Guidelines 2British School Kids With Diabetes Gain First Time Freedom From Injections With New Insulin Pump Guidelines 3British School Kids With Diabetes Gain First Time Freedom From Injections With New Insulin Pump Guidelines 4Preliminary Report of American Biotech Labs HIV Study Featured in Inaugural Issue of Journal of the Science of Healing Outcomes 2Pharmos Corporation Announces That it Will Cease Operations in Israel 2
...
... Western Blot Strong Antibody Stripping Solution is ... blots that have been developed with chemiluminescence ... is not recommended for stripping colorimetric substrates ... not possible to effectively remove substrates that ...
... Liquid. 100 ml supplied as a ... remove antibodies from membrane-bound proteins without ... stripping chemiluminescent or radioisotopic signals from ... Western blots. Supplied as a 5X ...
... is specifically designed for two-dimensional electrophoresis ... four proteins in this marker have ... pattern across a 2D gel. The ... Mol wt: 17,000-89,000 ...
Biology Products: